| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 09/05/2007 | EP1827497A2 Releasable polymeric conjugates based on aliphatic biodegradable linkers |
| 09/05/2007 | EP1827492A2 Antibodies directed to gpnmb and uses thereof |
| 09/05/2007 | EP1827483A2 Therapeutic formulations of keratinocyte growth factor |
| 09/05/2007 | EP1827475A1 Method for treatment of hiv infection |
| 09/05/2007 | EP1827464A1 Zinc-based compositions and methods of use |
| 09/05/2007 | EP1827455A1 Novel formulation of pyridoxal 5'-phosphate and method of preparation |
| 09/05/2007 | EP1827453A1 Sulfonylurea compositions and a process for its preparation |
| 09/05/2007 | EP1827428A1 Compositions comprising an epothilone and production methods |
| 09/05/2007 | EP1827413A1 Use of cyclodextrin complexes containing lipoic acid |
| 09/05/2007 | EP1827409A2 Rasagiline orally disintegrating compositions |
| 09/05/2007 | EP1827376A1 Visco-supplement composition and methods |
| 09/05/2007 | EP1576132A4 Nucleic acids and corresponding proteins entitled 273p4b7 useful in treatment and detection of cancer |
| 09/05/2007 | EP1357920B1 Compositions and method of tissue superoxygenation |
| 09/05/2007 | EP1283719B1 Apoptotic agents |
| 09/05/2007 | EP1259541B1 Amino acid sequences facilitating penetration of a substance of interest into cells and/or cell nuclei |
| 09/05/2007 | EP1093465B1 Method for producing or enhancing a t-cell response against a target cell using a complex comprising an hla class i molecule and an attaching means |
| 09/05/2007 | CN101031588A Drug compositions, fusions and conjugates |
| 09/05/2007 | CN101031323A Conjugates of gm-csf moiety and a polymer |
| 09/05/2007 | CN101031322A 固体药物制剂 The solid pharmaceutical preparation |
| 09/05/2007 | CN101031321A Perorally administrable antimicrobial composition |
| 09/05/2007 | CN101031308A Prodrugs activated by rna-dependent dna-polymerases |
| 09/05/2007 | CN101031303A Pharmaceutical compositions comprising zd6474 |
| 09/05/2007 | CN101031285A Composition containing fine particles and process for producing the same |
| 09/05/2007 | CN101031283A Pharmaceutical compositions for drug delivery and methods of treating or preventing conditions using same |
| 09/05/2007 | CN101031280A Skin coating composition and its application |
| 09/05/2007 | CN101029143A Controllable biological degradable polyester superfine fibrous film material |
| 09/05/2007 | CN101029136A Production and use for high-oxygen light-transmittance connected network |
| 09/05/2007 | CN101029131A Branching poly-ethylene and its production |
| 09/05/2007 | CN101029093A Chitin/polydioxide cyclohexanone graft copolymer and its production |
| 09/05/2007 | CN101028566A Method for removing organic solvent from heavy-bodied liquid |
| 09/05/2007 | CN101028524A Supersonic microvesicle target positioning controlled-release/gene device and target transferring method |
| 09/05/2007 | CN101028521A Oral colon positioning feed preparation based on electric spinning superfine nuclear fibre and its making method |
| 09/05/2007 | CN101028520A Target magnetic nickel nano-medicinal preparation for inhibiting tumor cell growth and its production |
| 09/05/2007 | CN101028512A Use of matrix metal protease inhibitor in preparation of medicine for treating nearsightedness |
| 09/05/2007 | CN101028461A Job's tears nut oil self-emusifying preparation and its making method |
| 09/05/2007 | CN101028450A Medicinal composition for treating cardica cerebrovascular diseases |
| 09/05/2007 | CN101028337A Salt-water liquid for irrigating nasal cavity |
| 09/05/2007 | CN101028318A Sustained andrographis paniculata preparation and its preparing method |
| 09/05/2007 | CN101028283A Use of fucans in the treatment of adhesions, arthritis and psoriasis |
| 09/05/2007 | CN101028281A Nano-gel pectin bismuth and its granules medicine |
| 09/05/2007 | CN101028276A Instant pyrobixi freeze-drying powdery injection and its production |
| 09/05/2007 | CN101028275A Use of alpha-D-glucose diglyceride in preparation of thrombolytic medicine |
| 09/05/2007 | CN101028273A Improved Enticawer suspension granules and their preparation |
| 09/05/2007 | CN101028272A Enticawer chewing tablets and their preparation |
| 09/05/2007 | CN101028271A Enticawer release-controllable capsules and their preparation |
| 09/05/2007 | CN101028270A Enticawer release-controllable tablet and its preparation |
| 09/05/2007 | CN101028268A Pharmaceutical compositions |
| 09/05/2007 | CN101028264A Huisanliu tablets as medicine and their preparation |
| 09/05/2007 | CN101028259A Water soluble paclitaxel product |
| 09/05/2007 | CN101028258A Medicinal composition containing ibuprofen |
| 09/05/2007 | CN101028254A Sustaining agent of Duosuo theosine and its preparation |
| 09/05/2007 | CN101028253A Composition comprising epigallocatechin gallate |
| 09/05/2007 | CN101028252A Injection acetylcysteine powdery medicinal composition and its making method |
| 09/05/2007 | CN101028249A Anti-cancer composition containing neoformative vascular inhibitor and alkylating agent |
| 09/05/2007 | CN101028248A Anti-cancer composition containing vascular inhibitor and topographic enzyme inhibitor |
| 09/05/2007 | CN101028247A Anti-cancer composition containing neoformative vascular inhibitor and alkaloid |
| 09/05/2007 | CN101028246A Anti-cancer composition containing neoformative vascular inhibitor and hormone medicine |
| 09/05/2007 | CN101028245A Anti-cancer composition with neoformative vascular inhibitor and phosphoinositide 3-inositol inhibitor carrier |
| 09/05/2007 | CN101028244A Anti-cancer composition containing neoformative vascular inhibitor and antimetabolite |
| 09/05/2007 | CN101028243A Anti-cancer composition containing neoformative vascular inhibitor and Eps mycin |
| 09/05/2007 | CN101028242A Preparation of anti-herpesvirus medicinal hollow fibre |
| 09/05/2007 | CN101028241A Medicinal hollow fibre, its production and use |
| 09/05/2007 | CN100335503C Polyol-ifn-beta conjugates |
| 09/05/2007 | CN100335136C Pharmaceutical composition having reduced tendency for drug crystallization |
| 09/05/2007 | CN100335135C Ginkgo leaf extract capsule composition and its prepn |
| 09/05/2007 | CN100335134C Nimodipine soft capsule and its prepn |
| 09/05/2007 | CN100335133C Non-gelatinous capsule film compositions and capsules using the same |
| 09/05/2007 | CN100335132C Combination therapy using receptor tyrosine kinase inhibitors and angiogenesis inhibitors |
| 09/05/2007 | CN100335124C IL-2 precursor liposome and its preparation method |
| 09/05/2007 | CN100335123C Method for improving oral drug living thing availability, composition and reagent box |
| 09/05/2007 | CN100335081C Composition containing moutan root bark extract as active ingredient |
| 09/05/2007 | CN100335063C Pharmaceutical composition |
| 09/05/2007 | CN100335048C Skin-whitening composition |
| 09/05/2007 | CN100335047C Aripiprazole complex formulation and method |
| 09/05/2007 | CN100335046C Composition |
| 09/05/2007 | CN100335045C Ascites preventives for poultry |
| 09/05/2007 | CN100335041C Palatable chewable tablet |
| 09/05/2007 | CN100335040C Rapidly disintegrating tablet comprising acid-sensitive active ingredient |
| 09/05/2007 | CN100335038C Preparation process and application of inorganic salt nanometer particle containing biological active material and enveloped Chinese medicinal ingredient |
| 09/05/2007 | CN100335037C Free-flowing, powdery composition containing alpha-liponic acid (-derivatives) |
| 09/05/2007 | CN100335036C Method and composition for dry eye treatment |
| 09/04/2007 | US7265296 Flame retardant plenum cable |
| 09/04/2007 | US7265201 Human chemotactic cytokine |
| 09/04/2007 | US7265186 Multi-arm block copolymers as drug delivery vehicles |
| 09/04/2007 | US7265157 Sustained release compositions, process for producing the same and use thereof |
| 09/04/2007 | US7265156 Medicinal association of a biguanine and a carrier, for example metformin and arginine |
| 09/04/2007 | US7265136 Substituted stilbene compounds with vascular damaging activity |
| 09/04/2007 | US7265117 Contain a preservative ingredient consisting of a combination of polyquaternium-1 and boric acid, ophthalmic solution |
| 09/04/2007 | US7265098 Polyacid/polyalkylene oxide gels and methods for their delivery |
| 09/04/2007 | US7265097 Delivering therapeutic formulation containing sulphated chitinous polymer as a primary carrier across a membrane that has limited permeability for therapeutic agent |
| 09/04/2007 | US7265086 Useful as antibacterial agents |
| 09/04/2007 | US7264965 Method for producing or enhancing a T-cell response against a target cell using a complex comprising an HLA class I molecule and an attaching means |
| 09/04/2007 | US7264826 Pharmaceutical compositions of cell lysate and processes for the production and use thereof |
| 09/04/2007 | US7264825 Pharmaceutical preparation with retarding active ingredient release, method for its production and its use |
| 09/04/2007 | US7264810 Scaffolds comprising epitopes and genetic engineered proteins of bacteriophages, used as vaccines, anticarcinogenic agents or antiallergens |
| 09/04/2007 | US7264800 Method and composition for inhibiting cancer cell growth |
| 09/04/2007 | US7264799 Administering to patient before or simultaneously with surgery at least one heparinase enzyme, wherein heparinase enzyme decreases localized inflammatory response in the tissue of the patient |
| 09/04/2007 | US7264795 having UV protection properties, characterized in that the formulation comprises at least one encapsulated organic sunscreen and does not penetrate the skin |
| 09/04/2007 | US7264629 Photodynamic therapy for the treatment of hair loss |
| 09/04/2007 | CA2444554C Pharmaceutical compositions of amlodipine and atorvastatin |